HYPERGLYCEMIA PER SE CAN REDUCE PLASMA-FREE FATTY-ACID AND GLYCEROL LEVELS IN THE ACUTELY INSULIN-DEFICIENT DOG

被引:18
作者
PARK, KS [1 ]
RHEE, BD [1 ]
LEE, KU [1 ]
LEE, HK [1 ]
KOH, CS [1 ]
MIN, HK [1 ]
机构
[1] SEOUL NATL UNIV, COLL MED, DEPT INTERNAL MED, SEOUL 151, SOUTH KOREA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1990年 / 39卷 / 06期
关键词
D O I
10.1016/0026-0495(90)90024-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the in vivo effect of hyperglycemia per se on plasma free fatty acid (FFA) and glycerol concentrations, euglycemic and hyperglycemic clamp studies were performed in six overnight fasted dogs in the state of insulin deficiency produced by somatostatin (SRIF) infusion. The mean blood glucose concentrations during the steady-state (the second hour of each study) averaged 4.65 ± 0.10 mmol/L in euglycemic clamp and 14.11 ± 0.10 mmol/L in hyperglycemic clamp. During the SRIF infusion, plasma FFA concentrations increased from 0.32 ± 0.05 μmol/mL at the basal state to 0.76 ± 0.04 μmol/mL at the steady-state in euglycemic clamp and from 0.26 ± 0.04 μmol/mL to 0.43 ± 0.02 μmol/mL in hyperglycemic clamp. Plasma glycerol concentrations increased from the basal value of 0.07 ± 0.01 μmol/mL to 0.15 ± 0.01 μmol/mL during the steady-state in euglycemic clamp and from 0.06 ± 0.01 μmol/mL to 0.08 ± 0.01 μmol/mL in hyperglycemic clamp. The steady-state concentrations of plasma FFA and glycerol in hyperglycemic clamp were significantly lower than those in euglycemic clamp (P < .001; respectively). These results suggest that hyperglycemia per se might decrease plasma FFA and glycerol concentrations at least in part by decreasing lipolysis in the acutely insulin-deficient dog. © 1990.
引用
收藏
页码:595 / 597
页数:3
相关论文
共 22 条
[1]   USE OF A HEATED SUPERFICIAL HAND VEIN AS AN ALTERNATIVE SITE FOR THE MEASUREMENT OF AMINO-ACID-CONCENTRATIONS AND FOR THE STUDY OF GLUCOSE AND ALANINE KINETICS IN MAN [J].
ABUMRAD, NN ;
RABIN, D ;
DIAMOND, MP ;
LACY, WW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (09) :936-940
[2]   GLUCOSE STIMULATION OF THE ANTI-LIPOLYTIC EFFECT OF INSULIN IN HUMANS [J].
ARNER, P ;
BOLINDER, J ;
OSTMAN, J .
SCIENCE, 1983, 220 (4601) :1057-1059
[3]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[4]  
FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133
[5]   INVIVO DEACTIVATION OF PERIPHERAL, HEPATIC, AND PANCREATIC INSULIN ACTION IN MAN [J].
GRAY, RS ;
SCARLETT, JA ;
GRIFFIN, J ;
OLEFSKY, JM ;
KOLTERMAN, OG .
DIABETES, 1982, 31 (10) :929-936
[6]  
LEE KU, 1988, DIABETOLOGIA, V31, P285
[7]   INSULIN DOSE-RESPONSE CHARACTERISTICS FOR SUPPRESSION OF GLYCEROL RELEASE AND CONVERSION TO GLUCOSE IN HUMANS [J].
NURJHAN, N ;
CAMPBELL, PJ ;
KENNEDY, FP ;
MILES, JM ;
GERICH, JE .
DIABETES, 1986, 35 (12) :1326-1331
[8]   EFFECT OF GLUCOSE AND INSULIN ON THE ESTERIFICATION OF FATTY ACIDS BY ISOLATED ADIPOSE TISSUE [J].
RABEN, MS ;
HOLLENBERG, CH .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (02) :435-439
[9]  
RANDLE PJ, 1963, LANCET, V1, P785
[10]   ANTIKETOGENIC EFFECT OF GLUCOSE PER-SE INVIVO IN MAN AND INVITRO IN ISOLATED RAT-LIVER CELLS [J].
RIOU, JP ;
BEYLOT, M ;
LAVILLE, M ;
DEPARSCAU, L ;
DELINGER, J ;
SAUTOT, G ;
MORNEX, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (07) :608-613